CLL: Treatment and Management Strategies for Best Outcomes - Episode 9
Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.
Related Content:
How I Truly Learned to Live With Stage 4 Colon Cancer
Truqap Combo May Improve Progression for Some With Prostate Cancer
Tips for Making a Thanksgiving Manageable With Cancer
Overcoming Hormone Therapy Resistance in Metastatic Breast Cancer